Related content

Liver Fatty Acid Binding Protein (L-FABP) as a Target for the Prevention of High Fat Diet Induced Obesity and Hepatic Steatosis

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 9, Iss. 1, 2009-03 ,pp. : 30-37

Bentham Science Publishers

Access to resources Recommend Favorite

Methylenetetrahydrofolate Reductase Polymorphism, Type II Diabetes Mellitus, Coronary Artery Disease, and Essential Hypertension in the Czech Population

By Beneš P.   Kaňková K.   Mužík J.   Groch L.   Benedík J.   Elbl L.   Izakovičová-Hollá L.   Vašků A.   Znojil V.   Vácha J.  

Molecular Genetics and Metabolism, Vol. 73, Iss. 2, 2001-06 ,pp. : 188-195

Academic Press

Access to resources Recommend Favorite

Personalized Strategies for the Diagnosis and Therapy of Type II Diabetes and Obesity

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 80-109

Bentham Science Publishers

Access to resources Recommend Favorite

Erratum to ''A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians'' [Mol. Genet. Metab. 78 (2003) 136-144]

By Wolford J.K.   Gruber J.D.   Ossowski V.M.   Vozarova B.   Antonio Tataranni P.   Bogardus C.   Hanson R.L.  

Molecular Genetics and Metabolism, Vol. 79, Iss. 3, 2003-07 ,pp. : 231-231

Elsevier

Access to resources Recommend Favorite

Hypogonadotrophic Hypogonadism in Type 2 Diabetes, Obesity and the Metabolic Syndrome

By  

Current Molecular Medicine, Vol. 8, Iss. 8, 2008-12 ,pp. : 816-828

Bentham Science Publishers

Access to resources Recommend Favorite